Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding

NARecruitingINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

June 21, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

August 31, 2026

Conditions
Acute Gastrointestinal Bleeding
Interventions
DEVICE

UI-EWD

Hemostatic powder administered at index endoscopy

DEVICE

Conventional therapy

Conventional endoscopic therapy (bipolar electrocoagulation or clips or argon plasma coagulation, with or without epinephrine injection) administered at index endoscopy

Trial Locations (15)

10016

RECRUITING

NYU Langone, New York

11030

RECRUITING

Northwell Health, Manhasset

35205

ACTIVE_NOT_RECRUITING

University of Alabama, Birmingham

60612

RECRUITING

RUSH University, Chicago

06520

RECRUITING

Yale, New Haven

02115

RECRUITING

Brigham and Women's Hospital, Boston

08901

RECRUITING

Rutgers University, Piscataway

Unknown

RECRUITING

McGill University, Montreal

RECRUITING

St. Michael's Hospital, Toronto

RECRUITING

Vancouver General Hospital, Vancouver

RECRUITING

Copenhagen University Hospital, Hvidovre

RECRUITING

Odense University Hospital, Odense

RECRUITING

St. Antoine, Paris

RECRUITING

Emek Medical Center, Afula

RECRUITING

Cleveland Clinic London, London

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

North American Science Associates Ltd.

NETWORK

lead

Medtronic - MITG

INDUSTRY

NCT06188585 - Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding | Biotech Hunter | Biotech Hunter